The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...

"The FDA will continue working with patients, drug companies and health care providers to address the unmet medical needs of the rare disease ... a warning for acute adrenal insufficiency or ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC ...

cSCC remains a disease ... severity. Adrenal insufficiency occurred in 0.9% (2/223) of patients receiving UNLOXCYT, including Grade 2 in 0.4% (1/223) of patients. UNLOXCYT can cause immune-mediated ...

Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

By Ronda Racha Penrice [This story contains spoilers from Jamie Foxx: What Had Happened Was…] The special begins with videos of fans speculating about Foxx’s illness. His daughter Corinne Foxx ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

The special begins with videos of fans speculating about Foxx’s illness. His daughter Corinne Foxx then takes the stage to thank the audience for coming. “This is a special moment for me and ...

Coronary heart disease can give you pain in your chest, called angina, or lead to a heart attack. It can also contribute to other heart problems, such as abnormal heart rhythms or heart failure.

10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore ... more likely to develop heart disease, researchers have ...